Atezolizumab-induced bilateral anterior uveitis: A case report

Atezolizumab-induced bilateral anterior uveitis: A case report

Purpose: To report a case of bilateral anterior uveitis undergoing atezolizumab treatment for advanced non-small cell lung cancer (NSCLC). Observations: A 64-year-old man was receiving atezolizumab for metastatic programmed cell death ligand 1 (PD-L1) positive NSCLC as first line therapy. Three week...

Full description

Bibliographic Details
Main Authors:	Tsuyoshi Mito, Shun Takeda, Nozomu Motono, Hiroshi Sasaki
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Atezolizumab PD-L1 inhibitor Anterior uveitis Immune-related adverse events (irAEs)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993621002140

Similar Items

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
by: Ryo Toyozawa, MD, et al.
Published: (2020-03-01)

Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC
by: Biagio Ricciuti, MD, et al.
Published: (2020-11-01)

Impact of BMI on Survival Outcomes of Immunotherapyin Solid Tumors: A Systematic Review
by: Alice Indini, et al.
Published: (2021-03-01)

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment
by: Xiaohu Zheng, et al.
Published: (2021-05-01)

Current approach in diagnosis and management of anterior uveitis
by: Agrawal Rupesh, et al.
Published: (2010-01-01)

A Case of Pseudoprogression During Atezolizumab Therapy  in Lung Adenocarcinoma
by: Xue WANG, et al.
Published: (2019-06-01)

Bilateral Anterior Uveitis Revealing Relapsing Polychondritis
by: Murat Hasanreisoğlu, et al.
Published: (2019-04-01)

Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series
by: Sarah Picard, et al.
Published: (2021-07-01)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
by: Alicia Quilez, MD, et al.
Published: (2020-03-01)

Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
by: Yuriko Ueki, et al.
Published: (2020-09-01)

Anterior uveitis by subconjunctival filariasis
by: Mauricio Casillas Villaseñor, et al.
Published: (2017-06-01)

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients
by: Peng Song, et al.
Published: (2020-09-01)

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
by: Vivek Kumar, et al.
Published: (2017-02-01)

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes
by: Charline Lafayolle de la Bruyère, et al.
Published: (2021-05-01)

Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab
by: Yuka Maya, MD, et al.
Published: (2020-12-01)

Immune Checkpoint Inhibitor-Associated Myocarditis
by: Grigorios Chatzantonis, MD, et al.
Published: (2020-04-01)

Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma
by: Jingrong Lin, et al.
Published: (2020-05-01)

Diagnosis and treatment of anterior uveitis: optometric management
by: Harthan JS, et al.
Published: (2016-03-01)

DRESS Syndrome Secondary to Carbamazepine Therapy Presenting with Bilateral Acute Anterior Uveitis and Angle Closure Glaucoma
by: Divya Karuppannasamy, et al.
Published: (2019-07-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
by: Pierpaolo Correale, et al.
Published: (2020-08-01)

Light microscopic examination of the anterior chamber cells in uveitis
by: Eiman Abd El-Latif
Published: (2017-01-01)

A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation
by: Tomoyo Oguri, et al.
Published: (2021-01-01)

Study of clinical and aetiological pattern of anterior uveitis in middle Karnataka
by: K M Sudha Madhavi, et al.
Published: (2015-01-01)

A clinical study of anterior uveitis at India
by: Pawan Jarwal
Published: (2021-01-01)

Bilateral uveitis following intravenous immunoglobulin administration
by: Enis D. Kocak, et al.
Published: (2017-06-01)

Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
by: Lei Zhang, et al.
Published: (2019-04-01)

Clinical approach to a case of anterior uveitis - A non-systematic review
by: Barkha Mehta, et al.
Published: (2021-01-01)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
by: Vanita Noronha, et al.
Published: (2021-03-01)

A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
by: Philip Friedlander, et al.
Published: (2018-09-01)

Polymerase chain reaction in unilateral cases of presumed viral anterior uveitis
by: Shoughy SS, et al.
Published: (2015-12-01)

A Review of Immune-Mediated Adverse Events in Melanoma
by: Lucy Boyce Kennedy, et al.
Published: (2019-07-01)

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy
by: Xiaowei Liu, et al.
Published: (2020-03-01)

Interdisciplinary collaboration in managing patients with anterior uveitis and spondyloarthritis
by: Cristina Stan, et al.
Published: (2020-06-01)

A Patient with Atezolizumab-Induced Autoimmune Diabetes Mellitus Presenting with Diabetic Ketoacidosis
by: Sharen Lee, et al.
Published: (2021-09-01)

An unusual case of bilateral anterior uveitis related to moxifloxacin: the first report in Latin America
by: Rangel, Carlos M., et al.
Published: (2017-07-01)

Preliminary results of retrospective analysis Atezolizumab and Bevacizumab in first-line therapy of advanced HCC
by: I. А. Dzhanyan, et al.
Published: (2021-06-01)

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
by: Aydin AM, et al.
Published: (2017-03-01)

Fibrinous anterior uveitis following laser <i> in situ</i> keratomileusis
by: Parmar Pragya, et al.
Published: (2009-01-01)

Clinical analysis of acute anterior uveitis in 215 cases
by: Xue-Wei Zhou, et al.
Published: (2013-11-01)